[Doctor's Column] Why Maunzaro is More Effective for Weight Loss Than Wigobi

[닥터칼럼] 마운자로가 위고비보다 체중감량 효과가 더 큰 이유

 

 

The reason why Maunzaro is more effective for weight loss than Wigobi

What will change if GIP is added?

 

[닥터칼럼] 마운자로가 위고비보다 체중감량 효과가 더 큰 이유

 

 

hello.

Studying the outer and inner layers of the skin Director Kim Tae-hee of Sunae May Pure Clinic no see.

 

In the previous post comparing Maunzaro and Wigobi

Maunzaro showed a greater weight loss effect on average. We have introduced the research results.

 

In that case, many people are curious.

"Why on earth does it fall out more easily?"

 

Today is the key point

GIP (Glucose-dependent Insulinotropic Polypeptide)

Let's find out about it.

 


 

The biggest difference between Wigobi and Maunzaro

 

Wigobi Is

Activation of only GLP-1 receptors do.

 

the other side Maunzaro Is

✔ GLP-1

✔ GIP

It activates two hormones simultaneously.

 

So, Maunzaro

Dual Incretin Therapy or Twincretin It is called.


What kind of hormone is GIP originally?

 

GIP is also secreted in the small intestine when you eat. Incretin hormone no see.

In the past, it was known as a hormone involved only in blood sugar regulation, but

Recent studies have revealed that it plays a very important role in obesity treatment.

 


 

What will GIP do?

 

[닥터칼럼] 마운자로가 위고비보다 체중감량 효과가 더 큰 이유

 

Recent studies report that GIP is involved in the following actions.

 

① Appetite control

It may act on the hypothalamus in conjunction with GLP-1 to suppress appetite more effectively.

 

② Energy Metabolism

Studies are being published suggesting that it can affect not only food intake but also energy consumption. Although the full mechanisms in humans have not yet been fully elucidated, positive results are being reported in animal experiments and clinical studies.

 

③ Fat Metabolism Function

Recent studies suggest that GIP may also be involved in the function and metabolism of fat cells. Rather than simply "burning fat" It can affect the metabolic regulation of adipose tissue. Understanding it that way is more in line with the current basis.

 

④ Possibility of enhancing the effects of GLP-1

This is currently the most 주목받는 (highly anticipated) aspect. Compared to GLP-1 alone

If you activate GIP together

  • Increased satiety

  • loss of appetite

  • Blood sugar control

The key point of current obesity treatment research is that the effect can be even greater.

 


 

So, what is the actual weight loss effect?

 

STEP-1 (Wigobi large-scale clinical trial)

 

Wigobi(S emaglutide), 68 weeks of use, average 14.9% weight loss

 

 


 

SURMOUNT-1 (Maunzaro large-scale clinical trial)

 

Maunzaro (Tirzepatide), 72 weeks of use, average 15~21% weight loss

At maximum capacity More than half of the patients lost 20% or more.


 

SURMOUNT-5 Direct Comparison (Large-scale clinical trial comparing Wigobi vs. Maunzaro)

 

A study published in 2025 directly compared the two drugs.

Maunzaro

Wigobi

Average weight loss

20.2% decrease

13.7% decrease

Waist circumference reduction

18.4cm decrease

13.0cm decrease

 

In other words, large-scale studies published to date have shown that Maunzaro has, on average, a greater weight loss effect.

 


 

Then, is GIP everything?

 

Not yet.

 

Researchers are currently continuing to investigate exactly what mechanisms create these differences.

 

So far

Synergistic effect of GLP-1 and GIP to increase weight loss

It is thought to play an important role.

 

However, GIP alone is insufficient to explain it, and it is most accurate to understand it as a complex mechanism working together.

 


 

The important thing is

 

Every medicine has its pros and cons.

Maunzaro is not necessarily more suitable for everyone.

The following factors must be considered together.

 

✔ BMI

✔ Diabetes status

✔ Target weight

✔ Previous medication use experience

✔ Gastrointestinal diseases

✔ Risk of side effects

 

Therefore, it is important to select the treatment suitable for the individual through sufficient consultation with medical staff.

 


 

📚 References (Searchable on PubMed / Google Scholar)

  1. Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022;387:205-216. (SURMOUNT-1)

  2. Aronne LJ, et al. Tirzepatide as Compared with Semaglutide for the Treatment of Obesity. N Engl J Med. 2025. (SURMOUNT-5)

  3. Frias JP, et al. Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. N Engl J Med. 2021;385:503-515. (SURPASS-2)

  4. Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384:989-1002. (STEP-1)

  5. Holst JJ, Rosenkilde MM. GIP as a Therapeutic Target in Diabetes and Obesity: Insight From Incretin Co-agonists. Nat Rev Endocrinol. 2020.

  6. Samms RJ, et al. GIP receptor agonism mediates weight loss and improves metabolic control when combined with GLP-1 receptor agonism. Cell Metabolism. 2021.


 

[Mandatory Notices for Compliance with Medical Act]

※ All dermatological procedures may result in side effects, ranging from minor to major, such as erythema, swelling, burns, inflammation, and cheek hollowing, depending on an individual's skin condition and characteristics. This post is written for the purpose of providing medical information and does not guarantee 100% of the results of any specific procedure. Please be sure to have a thorough in-person consultation with experienced medical professionals before the procedure.


 

Director Kim Tae-hee of Maypure Clinic Sunae Branch

 

· Graduated from Chonnam National University School of Medicine

· Internal Medicine Specialist at Chonnam National University Hospital

· (Former) Clinical Professor, Department of Pulmonology, Gangnam Severance Hospital

· (Former) Assistant Professor, Department of Pulmonology, Kangnam Sacred Heart Hospital

· Regular member of the Korean Society of Internal Medicine

· Regular member of the Korean Society of Tuberculosis and Respiratory Diseases

· Member of the Korean Society of Cosmetology

  

 

👉 [Go to Maypure for free real-time consultation] https://pf.kakao.com/_ljPqE 

[닥터칼럼][리프팅③] '덴서티'가 프리미엄 리프팅의 새로운 기준이 된 결정적 이유

 


 

📢 Maypure Maunzaro Launch

✅ Free consultation

✅ At Sunae May Pure Clinic Personalized prescriptions are available after consultation with medical staff specializing in family medicine and internal medicine.

 


 

🔎 You can find more dermatology content by searching for "Sunae May Pure Blog" on Naver. 

 

<The Maunzaro Series Recommended for Reading Together>

 

👉Maunzaro vs. Wigovi

https://blog.naver.com/dr_insideout/224336141708 

👉 Why Maunzaro is more effective for weight loss than Wigobi

https://blog.naver.com/dr_insideout/224336167993 

Can people with a normal weight be prescribed Maunzaro?

https://blog.naver.com/dr_insideout/224336200371 

👉Comprehensive Summary of Maunzaro Side Effects

https://blog.naver.com/dr_insideout/224336242086 

Will I lose muscle if I get hit by Maunzaro?

https://blog.naver.com/dr_insideout/224336865164 

👉Maunzaro vs. Wigovi, the shocking result shown by NEJM SURMOUNT-5

https://blog.naver.com/dr_insideout/224340190611 

Will I gain weight again if I stop Maunzaro?

https://blog.naver.com/dr_insideout/224340258185 

👉 Is a side effect of Maunzaro presbyopia? The truth about Ozempic Face

https://blog.naver.com/dr_insideout/224341513780 

👉 A diet to lose weight while protecting your face

https://blog.naver.com/dr_insideout/224341756348 

Comments0